A survey of optimization models on cancer chemotherapy treatment planning
From MaRDI portal
Publication:478056
DOI10.1007/s10479-011-0869-4zbMath1304.49002OpenAlexW2060085351MaRDI QIDQ478056
Oguzhan Alagoz, Fatih Safa Erenay, Qiang Su, Jinghua Shi
Publication date: 11 December 2014
Published in: Annals of Operations Research (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1007/s10479-011-0869-4
Lua error in Module:PublicationMSCList at line 37: attempt to index local 'msc_result' (a nil value).
Related Items (12)
Personalized drug administration for cancer treatment using model reference adaptive control ⋮ Optimal control of cancer chemotherapy with delays and state constraints ⋮ Optimal switching control for drug therapy process in cancer chemotherapy ⋮ Optimized drug regimen and chemotherapy scheduling for cancer treatment using swarm intelligence ⋮ Optimizing antimicrobial treatment schedules: some fundamental analytical results ⋮ On a multiobjective optimal control of a tumor growth model with immune response and drug therapies ⋮ Optimizing multi-modal cancer treatment under 3D spatio-temporal tumor growth ⋮ Tumor clearance analysis on a cancer chemo-immunotherapy mathematical model ⋮ Optimal sequencing of heterogeneous, non-instantaneous interventions ⋮ Model predictive tumour volume control using nonlinear optimization ⋮ A NEW MATHEMATICAL MODELING AND SUB-OPTIMAL CHEMOTHERAPY OF CANCER ⋮ Optimal control oriented to therapy for a free-boundary tumor growth model
Cites Work
- Unnamed Item
- Unnamed Item
- Unnamed Item
- Unnamed Item
- Unnamed Item
- A mathematical model of the effects of drug resistance in cancer chemotherapy
- Role of optimal control theory in cancer chemotherapy
- On optimal delivery of combination therapy for tumors
- A model for the resistance of tumor cells to cancer chemotherapeutic agents
- The effect of cellular differentiation on the development of permanent drug resistance
- Models for dose intensity
- Optimal control of tumor size used to maximize survival time when cells are resistant to chemotherapy
- Low-intensity combination chemotherapy maximizes host survival time for tumors containing drug-resistant cells
- Optimal control analysis in the chemotherapy of IgG multiple myeloma
- Mathematical approaches to optimization of cancer chemotherapy
- Optimal drug regimens in cancer chemotherapy for single drugs that block progression through the cell cycle
- Chemotherapeutic treatments: A study of the interplay among drug resistance, toxicity and recuperation from side effects
- A mathematical model of drug resistance: Heterogeneous tumors
- The dynamics of an optimally controlled tumor model: A case study
- A mathematical model to study the effects of drug resistance and vasculature on the response of solid tumors to chemotherapy
- Optimal control for a stochastic model of cancer chemotherapy
- Some optimal control problems in cancer chemotherapy with a toxicity limit
- A stochastic model for the origin and treatment of tumors containing drug-resistant cells
- A mathematical model of cycle-specific chemotherapy
- A mathematical model of periodically pulsed chemotherapy: Tumor recurrence and metastasis in a competitive environment
- Nondominated decisions and cone convexity in dynamic multicriteria decision problems
- A mathematical model of cancer chemotherapy with an optimal selection of parameters
- Chemotherapy for tumors: An analysis of the dynamics and a study of quadratic and linear optimal controls
- Optimal control of treatment in a mathematical model of chronic myelogenous leukemia
- The Optimal Timing of Living-Donor Liver Transplantation
- Optimizing Chemotherapy Scheduling Using Local Search Heuristics
- Determining the Acceptance of Cadaveric Livers Using an Implicit Model of the Waiting List
- Approximate Dynamic Programming
This page was built for publication: A survey of optimization models on cancer chemotherapy treatment planning
